000			02053 a2200553 4500
005			20250515201924.0
264		0	_c20100305
008			201003s 0 0 eng d
022			_a1941-7632
024	7		_a10.1161/CIRCINTERVENTIONS.108.847996 _2doi
040			_aNLM _beng _cNLM
100	1		_aGurm, Hitinder S
245	0	0	_aA comparison of abciximab and small-molecule glycoprotein IIb/IIIa inhibitors in patients undergoing primary percutaneous coronary intervention: a meta-analysis of contemporary randomized controlled trials. _h[electronic resource]
260			_bCirculation. Cardiovascular interventions _cJun 2009
300			_a230-6 p. _bdigital
500			_aPublication Type: Journal Article; Meta-Analysis
650	0	4	_aAbciximab
650	0	4	_aAged
650	0	4	_aAngioplasty, Balloon, Coronary _xadverse effects
650	0	4	_aAntibodies, Monoclonal _xadverse effects
650	0	4	_aEptifibatide
650	0	4	_aFemale
650	0	4	_aHemorrhage _xchemically induced
650	0	4	_aHumans
650	0	4	_aImmunoglobulin Fab Fragments _xadverse effects
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMyocardial Infarction _xmortality
650	0	4	_aOdds Ratio
650	0	4	_aPeptides _xadverse effects
650	0	4	_aPlatelet Aggregation Inhibitors _xadverse effects
650	0	4	_aPlatelet Glycoprotein GPIIb-IIIa Complex _xantagonists & inhibitors
650	0	4	_aRandomized Controlled Trials as Topic
650	0	4	_aRecurrence
650	0	4	_aRisk Assessment
650	0	4	_aRisk Factors
650	0	4	_aThrombosis _xetiology
650	0	4	_aTime Factors
650	0	4	_aTirofiban
650	0	4	_aTreatment Outcome
650	0	4	_aTyrosine _xadverse effects
700	1		_aTamhane, Umesh
700	1		_aMeier, Pascal
700	1		_aGrossman, P Michael
700	1		_aChetcuti, Stanley
700	1		_aBates, Eric R
773	0		_tCirculation. Cardiovascular interventions _gvol. 2 _gno. 3 _gp. 230-6
856	4	0	_uhttps://doi.org/10.1161/CIRCINTERVENTIONS.108.847996 _zAvailable from publisher's website
999			_c19412114 _d19412114